Patients with AMS have been observed to have elevated levels of proinflammatory cytokines IL-6, -1α, and-1β, and TNF-α, and decreased levels of the anti-inflammatory cytokine IL-10 [44, 45]. The gene discussed is IL6; the disease is ablepharon macrostomia syndrome.